Second paediatric strategy forum on medicine development for mature B cell malignancies in children

Date: 13/11/2017 to 14/11/2017
Location: European Medicines Agency, London, UK
This second multi-stakeholder paediatric strategy forum, jointly organised by ACCELERATE and the European Medicines Agency, will focus on mature B cell malignancies (lymphoma and leukaemia) in children. The goal of this meeting is to share information, in a pre-competitive setting, which will inform a paediatric drug development strategy and subsequent decisions and facilitate the developments of innovative medicines for the treatment of children with mature B cell malignancies. Participation is restricted and on invitation only. Interested parties, including patients and parent-representatives, academia, clinicians and industry, should express their interest. For clinicians and researchers, priority will be given to those who have expertise and experience in clinical trials for mature B cell malignancies in children or intend to design such studies in the future.The report of this forum will be published as a scientific paper.

How useful was this page?

Add your rating
3 ratings
4 ratings
5 ratings
2 ratings